A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation

This pilot study evaluates the degree of side effects during high-dose chemotherapy (HD-VIC) plus autologous bone marrow transplant (HDCT) and its possible prevention by the cytoprotective thiol-derivate amifostine. Additionally, the in-patient medical costs of both treatment arms were compared. 40...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartmann, J T, Vangerow, A von, Fels, L M, Knop, S, Stolte, H, Kanz, L, Bokemeyer, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363753/
https://www.ncbi.nlm.nih.gov/pubmed/11161394
http://dx.doi.org/10.1054/bjoc.2000.1611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363753/
https://www.ncbi.nlm.nih.gov/pubmed/11161394
http://dx.doi.org/10.1054/bjoc.2000.1611

Ejemplares similares